Cargando...
Long‐Term Efficacy of a Double‐Blind, Placebo‐Controlled, Randomized Study for Repetitive Sphenopalatine Blockade With Bupivacaine vs Saline With the Tx360(®) Device for Treatment of Chronic Migraine
BACKGROUND: This study aims to determine if repetitive sphenopalatine ganglion (SPG) blockades with 0.5% bupivacaine delivered with the Tx360(®) device results in long‐term improvement in chronic migraine (CM). The SPG is a small concentrated structure of neuronal tissue that resides within the pter...
Guardado en:
| Publicado en: | Headache |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681144/ https://ncbi.nlm.nih.gov/pubmed/25828648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.12546 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|